- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04619030
Augmented Reality (AR): The Future of "Patient Information Leaflets
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
At present, the traditional approach to patient education regarding diseases such as a new cancer diagnosis, is the patient information leaflet. Patient information leaflets often fail to convey the required medical information due to poor levels of literacy in the population, with 20% patients in the UK having the lowest level of adult literacy (equivalent to an individual who is unable to determine how much medicine to give a child from information printed on the package). "Health literacy" - the ability to obtain, understand, act on and communicate health information - is even lower, with estimates that 40% of patients have inadequate levels of health literacy. Additionally, there is a large knowledge gap between what doctors perceive patients understand about an illness, medication, or operation, and what patients actually comprehend and retain during consultation.
The plethora of problems of inadequate information, poor health literacy and patient-doctor knowledge disconnect, may be addressed with an approach to patient information leaflets using a platform that is entirely simulative and visual, thereby overcoming the problem of health literacy. The study builds upon pilot work by this research team on patient leaflets using AR to aid in patient education, visualisation and retention of information (Lo et al 2019).
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Scotland
-
Glasgow, Scotland, United Kingdom, G51 4TF
- Recruiting
- Royal Hospital For Children
-
Contact:
- Steven Lo
- Phone Number: 01412114000
- Email: Steven.lo@ggc.scot.nhs.uk
-
Glasgow, Scotland, United Kingdom, G4 0SF
- Recruiting
- Glasgow Royal Infirmary
-
Contact:
- Steven Lo
- Phone Number: 01412114000
- Email: Steven.lo@ggc.scot.nhs.uk
-
Glasgow, Scotland, United Kingdom, G4 0SF
- Recruiting
- Canniesburn Regional Plastic Surgery and Burns Unit
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patients who have undergone reconstructive surgery
- patients who are awaiting reconstructive surgery
- patients with sarcoma
- patients with breast cancer
- patients with reconstructive flaps
- patients with or parents of patients with cleft lip and palate
- Patients with dyslexia will be included
Exclusion Criteria:
- Cannot speak or read English
- Blind/severely visually impaired
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Augmented Reality Leaflet
Patient Leaflet with Augmented reality component
|
The patient leaflet has an Augmented Reality model that appears out of the leaflet when viewed with a smartphone
|
|
Active Comparator: Traditional Leaflet
Traditional leaflet without Augmented Reality component
|
Traditional leaflet with no Augmented Reality capability
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mental Effort Rating Scale
Time Frame: Single point at day 1 (Patient assesses leaflet once after reading leaflet)
|
Validated scale for cognitive load/ ease of understanding leaflet.
Single item scale with rating 1 = very, very low mental effort to 9 = very, very high mental effort.
Lower score is better
|
Single point at day 1 (Patient assesses leaflet once after reading leaflet)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall Patient Satisfaction
Time Frame: Single point at day 1 (Patient assesses leaflet once after reading leaflet)
|
Visual analogue scale, overall satisfaction with patient leaflet.
Visual analogue scale will be converted to numerical scale 0-100, with higher being better or more satisfied
|
Single point at day 1 (Patient assesses leaflet once after reading leaflet)
|
|
Instructional Motivation Materials Survey
Time Frame: Single point at day 1 (Patient assesses leaflet once after reading leaflet)
|
Assessment of patient learning motivation after reading leaflet.
36 items, each item rated by Likert scale 1-5.
Higher score is better.
|
Single point at day 1 (Patient assesses leaflet once after reading leaflet)
|
|
Usefulness Scale for Patient Information (USE scale)
Time Frame: Single point at day 1 (Patient assesses leaflet once after reading leaflet)
|
9 item scale with Likert rating 0-10 for each item.
Total score out of 90, with 3 sub scales measuring cognitive, emotional and behavioural dimensions.
Higher score is better.
|
Single point at day 1 (Patient assesses leaflet once after reading leaflet)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subjective interview
Time Frame: Single point at day 1 (Patient assesses leaflet once after reading both leaflets)
|
Patients will be interviewed regarding opinions of the two types of patient leaflet.
|
Single point at day 1 (Patient assesses leaflet once after reading both leaflets)
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GN19HS442
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sarcoma
-
Children's Oncology GroupActive, not recruitingMetastatic Ewing Sarcoma | CIC-Rearranged Sarcoma | Round Cell Sarcoma With EWSR1-non-ETS Fusion | Metastatic High Grade Sarcoma | Sarcoma With BCOR Genetic Alterations | Metastatic Undifferentiated Round Cell Sarcoma | Metastatic Undifferentiated Sarcoma, Not Otherwise SpecifiedUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedBone Sarcoma | Retroperitoneal Sarcoma | Adult Soft Tissue SarcomaUnited States
-
National Cancer Institute (NCI)RecruitingMetastatic Alveolar Soft Part Sarcoma | Unresectable Alveolar Soft Part Sarcoma | Advanced Soft Tissue Sarcoma | Advanced Alveolar Soft Part Sarcoma | Refractory Alveolar Soft Part SarcomaUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)TerminatedUterine Corpus Leiomyosarcoma | Stage IIA Uterine Sarcoma | Stage IIB Uterine Sarcoma | Stage IIIA Uterine Sarcoma | Stage IIIB Uterine Sarcoma | Stage IIIC Uterine Sarcoma | Stage IVA Uterine Sarcoma | Stage IVB Uterine Sarcoma | Stage IA Uterine Sarcoma | Stage IB Uterine Sarcoma | Stage IC Uterine SarcomaUnited States
-
National Cancer Institute (NCI)CompletedRhabdomyosarcoma | Synovial Sarcoma | Ewing's Sarcoma | MPNST | High-risk SarcomaUnited States
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI)Not yet recruitingSkin Kaposi Sarcoma | AIDS-Related Kaposi SarcomaUnited States
-
Mohammed M MilhemGenentech, Inc.CompletedSarcoma | Soft Tissue Sarcoma | Metastatic Sarcoma | Locally Advanced Sarcoma | Unresectable SarcomaUnited States
-
Royal Marsden NHS Foundation TrustFondazione IRCCS Istituto Nazionale dei Tumori, Milano; Cancer Research UK; University... and other collaboratorsRecruitingSarcoma | Soft Tissue Sarcoma Adult | Liposarcoma | Angiosarcoma | Soft Tissue Sarcoma of the Limb | Retroperitoneal Sarcoma | Liposarcoma, Dedifferentiated | Leiomyosarcoma (LMS) | Soft Tissue Sarcoma of the Trunk and Extremities | Soft Tissue Sarcoma (STS) | Sarcoma, Leiomyo-, Adult | Sarcoma, Synovial, AdultUnited Kingdom
-
Epizyme, Inc.TerminatedAdvanced Soft-tissue Sarcoma | Advanced Epithelioid SarcomaUnited States, Taiwan, United Kingdom, Canada
-
Advenchen Laboratories, LLCRecruitingLeiomyosarcoma | Synovial Sarcoma | Alveolar Soft Part Sarcoma | Soft-Tissue SarcomaUnited States, United Kingdom, Spain, China, Italy
Clinical Trials on Augmented Reality
-
H. Lee Moffitt Cancer Center and Research InstituteNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)Completed
-
Vanderbilt University Medical CenterVanderbilt University; National Institute for Biomedical Imaging and Bioengineering...Completed
-
Chinese University of Hong KongCompleted
-
University of PittsburghNortheastern University; NSFRecruiting
-
Vanderbilt University Medical CenterVanderbilt University; National Institute for Biomedical Imaging and Bioengineering...Completed
-
Koç UniversityKoç University HospitalCompleted
-
Vanderbilt University Medical CenterVanderbilt University; National Institute for Biomedical Imaging and Bioengineering...Recruiting
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaUniversity of BolognaRecruiting
-
Brigham and Women's HospitalWithdrawnPain | Infection | MalignancyUnited States
-
Stanford UniversityCompletedAcute Pain | Mobility Limitation | Spinal FusionUnited States